New Gilead (GILD) Hire Makes Incyte (INCY) a Likely Takeover Target - Gabelli
Tweet Send to a Friend
Incyte (NASDAQ: INCY) is modestly higher (+0.85%) after Gabelli analyst Jing He said Gilead Sciences' (NASDAQ: GILD) new head of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
